论文部分内容阅读
AIM:To evaluate the feasibility and safety of No.13lymphadenectomy in radical gastrectomy for gastric carcinoma.METHODS:Medical records of the patients undergone No.13 lymph node dissection during D2 gastrectomy for gastric carcinoma,were reviewed from March 2003 to May 2007.RESULTS:One hundred and fifty-eight patients underwent No.13 lymph node dissection for D2 gastric carcinoma,of them,4 (2.53%) were found to have metastasis in No.13 lymph node.Metastasis to No.12 lymph node was detected in 6 patients and 4 of them had positive No.13 lymph node.The operative morbidity except for wound infection was 15.19% (24/158),and hospital death rate was 1.27% (2/158).No obstructive jaundice caused by No.13 lymph node metastasis after No.13 lymph node dissection in radical gastrectomy for gastric carcinoma was detected during the follow-up study to end of January 2007.CONCLUSION:Dissection of No.13 lymph node in D2 gastrectomy for gastric carcinoma is safe with a low morbidity and mortality rate.Further study is needed to explore its long-term effect.